학술논문
493TiP A CRUK phase I/IIA, first in human dose-escalation and expansion trial of HMBD-001 (an anti-HER-3 antibody) in patients with advanced HER3-positive solid tumours
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S767-S767
Subject
Language
ISSN
0923-7534